Health & Life Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 13, 2022 at 06:18 pm EDT
Share
Health & Life Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 147 million compared to TWD 211.42 million a year ago. Net loss was TWD 11.46 million compared to net income of TWD 21.63 million a year ago. Basic loss per share from continuing operations was TWD 0.24 compared to basic earnings per share from continuing operations of TWD 0.46 a year ago. Diluted loss per share from continuing operations was TWD 0.24 compared to diluted earnings per share from continuing operations of TWD 0.46 a year ago.
Health & Life Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of medical equipment. The Company's mainly provides electronic sphygmomanometers, such as blood pressure monitors, nebulizers and blood glucose monitoring systems, which are used to measure and record systolic and diastolic blood pressure and glucose of human beings. The Company distributes its products within domestic market and to overseas markets.